Faculty Experts

As one of the nation’s leading comprehensive cancer centers, our groundbreaking discoveries are changing the way the world diagnoses, treats and prevents cancer.

The cancer experts at Ohio State fuel the groundbreaking discoveries that will lead to our goal of a cancer-free world.

If you would like one of our experts to address a specific cancer-related matter please contact us.

  • Briefing Points to Need for Sustained Research Funding

    Sustaining federal funding for cancer research would not only boost the economy but also lead to discoveries and developments that improve patient care.

    U.S. Rep. Mary Jo Kilroy, a member of the congressional cancer caucus who addressed the importance of National Institutes of Health (NIH) funding on job growth and increased output of goods and services.

    Also on hand were OSUCCC Director and James CEO Michael A. Caligiuri, MD, and Dick Woodruff, senior vice president of federal relations for the American Cancer Society Cancer Action Network, who discussed the role research plays in driving discoveries and the ACS role in sustaining funding for investigators.

    In addition, ACS grantee Metin Gurcan, PhD, from Ohio State’s Department of Bioinformatics, and Pierluigi Porcu, MD, of the Division of Hematology and Oncology at Ohio State, presented their work in computer-aided clinical imaging for cutaneous lymphomas, work that is funded in part by a $29,402 grant from the ACS.

    Porcu, Gurcan and Henry Wong, MD, PhD, of the Division of Dermatology at Ohio State, have formed a multidisciplinary team that brings together expertise in laboratory research, clinical trials, and computer-based image analysis. Their work with image analysis of cutaneous lymphomas shows how development of new technologies and laboratory discoveries can be quickly applied to address unsolved clinical questions.

  • OSUCCC Director and James CEO Michael A. Caligiuri, MD speaks at the third annual Ovarian Cancer Awareness Press Conference

    Michael A. Caligiuri, MD (far right),was a speaker at the third annual Ovarian Cancer Awareness Press Conference co-sponsored by the Ovarian Cancer Alliance of Ohio and the Black Nurses Coalition at the Statehouse Atrium.

    “Our cancer physicians and researchers are working to reduce the burden of ovarian cancer,” Caligiuri says. “We are investigating novel methods to identify women at risk for developing this disease prior to its occurrence. If research such as this continues to be promising, we hope that one day women at risk can undergo prevention and screening to improve outcomes. We must continue to support education, research and treatment for ovarian cancer.”

    Also shown above from left are Kathy Lucas, ovarian cancer survivor; Jeffrey Bell, MD, medical director of cancer services and chief of oncology clinical operations council at Riverside Methodist Hospital; Alvin Jackson, MD, director of the Ohio Department of Health; Jackie Ludaway, ovarian cancer survivor; Ohio State Sen. Sue Morano, 13th District; and Ohio State Sen. Nina Turner, 25th District.

  • Steven Devine, M.D., Director of the Blood and Marrow Transplant Program at Ohio State's Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute provides expert testimony for donation of umbilical cord blood.

    Steven Dvine, M.D. (left) is shown with the bill's sponsor, Rep. Todd Book (D-McDermott, right) prior to Devine's testimony before the Senate House Committee.

    "Umbilical cord blood (UCB) donations have been increasingly used as a source of cells needed for transplants for adult and pediatric patients with cancers amenable to blood and bone marrow transplantation, such as leukemia, lymphoma and myeloma. We believe UCB represents an exciting and important new source of cells for patients who might be saved by a bone marrow transplant but who lack a suitable living donor. Therefore, educating women on the importance of the UCB banking program is an important element to increase banking participation, and producing additional UCB samples to benefit patients who otherwise have no transplantation options."

  • Director of the Division of Dermatology at Ohio State's Medical Center, Mark Bechtel, MMD provides expert testimony for HB 173

    Mark Bechtel, M.D., (right), spoke in support of House Bill 173 at the press conference, which recognized May as Melanoma/Skin Cancer Detection and Awareness Month in Ohio

    “As a physician, I have become increasingly alarmed by the increase in the number of my young patients presenting with melanoma and other skin cancers caused by excessive exposure to ultraviolet radiation in tanning beds,” Bechtel said. “Ohio must take action in enacting House Bill 173 to ensure that minors are no longer exposed to the harmful human carcinogens produced by tanning beds.”

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) 460 W. 10th Avenue, Columbus, OH 43210 Phone: 1-800-293-5066 | Email: jamesline@osumc.edu